Treatment of eosinophilic esophagitis: Overview, current limitations, and future direction

Matthew Bohm, Joel E. Richter

Research output: Contribution to journalReview article

40 Scopus citations

Abstract

Eosinophilic esophagitis (EE) is an increasingly recognized syndrome presenting with upper gastrointestinal (UGI) symptoms in association with hypereosinophilia (>15 eosinophils/HPF) on esophageal mucosal biopsies. The pathogenesis is unknown, but the candidate etiologies include food and aeroallergen hypersensitivity and an unusual presentation of gastroesophageal reflux disease. This review will highlight the treatments of EE in children and adults. Current treatments are controversial, few data are available in adults, and long-term studies are almost nonexistent. We outline the limitations in the current studies and suggest seven major issues in the study design that must be addressed in future drug trials.

Original languageEnglish (US)
Pages (from-to)2635-2644
Number of pages10
JournalAmerican Journal of Gastroenterology
Volume103
Issue number10
DOIs
StatePublished - Oct 1 2008
Externally publishedYes

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Treatment of eosinophilic esophagitis: Overview, current limitations, and future direction'. Together they form a unique fingerprint.

  • Cite this